← Back to Search

Behavioral Intervention

Embodied Conversational Agent (ECA) for Palliative Care (ECA-PAL Trial)

N/A
Waitlist Available
Led By Michael Paasche-Orlow, MD, MPH
Research Sponsored by Boston Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at 6 months
Awards & highlights

ECA-PAL Trial Summary

This trial will test whether or not a system that provides easy to use technologies to empower patients can reduce suffering for palliative care patients and their caregivers.

ECA-PAL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at enrollment and at 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at enrollment and at 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality of Life of palliative cancer care participants
Secondary outcome measures
Advance Care Planning and preferences
Cost
Hospital utilization
+11 more

ECA-PAL Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Embodied Conversational Agent (ECA)Experimental Treatment1 Intervention
In this arm the subject is trained how to use a tablet device which they take home for the duration of the study. These subjects complete the baseline interview, monthly telephone surveys about their quality of life, and the exit interview at 6 months after enrollment.
Group II: Control Usual CareActive Control1 Intervention
In this arm the subject receives usual care and just completes the baseline interview, monthly telephone surveys about their quality of life, and the exit interview at 6 months after enrollment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Embodied Conversational Agent (ECA)
2017
N/A
~370

Find a Location

Who is running the clinical trial?

Boston Medical CenterLead Sponsor
382 Previous Clinical Trials
869,032 Total Patients Enrolled
3 Trials studying Palliative Care
11,439 Patients Enrolled for Palliative Care
Northeastern UniversityOTHER
87 Previous Clinical Trials
59,193 Total Patients Enrolled
Boston UniversityOTHER
454 Previous Clinical Trials
9,941,203 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~48 spots leftby Apr 2025